Top Markets
#1 Islamic Coin Islamic Coin +151.45%
#2 DOVU DOVU +49.92%
#3 Velvet Velvet +43.90%
#4 Black Phoenix Black Phoenix +34.98%
#5 Fake World Assets Fake World Assets +19.35%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.99%
#7 DoubleZero DoubleZero +18.67%
#8 Akedo Akedo +18.04%
#9 HOME HOME +14.34%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.01%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
Rang in aandelen #39771
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Aandeelprijs
$0.26
Laatst gesynchroniseerd: 2024-03-11
Marktkapitalisatie
$356.29K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel InVivo Therapeutics Holdings Corporation (NVIV)

Categorie

Healthcare
Winst voor InVivo Therapeutics Holdings Corporation (NVIV)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van InVivo Therapeutics Holdings Corporation bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van InVivo Therapeutics Holdings Corporation van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE